RxDoctor Payments Data

Jerry Harvey, DO

Family Medicine · Cabot, ARNPI 1487602470

Payments from drug & device makers

$693in general payments, 2019–2025

Across 43 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$157
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$98
  • AbbVie$91
  • AstraZeneca$52
  • Novo Nordisk$39
  • Lilly USA, LLC$32
  • plus $224 from 13 others

What the payments were for

  • Food & beverage$693100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$693 in reported general payments places this provider in the 50th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$134,878
Medicare patients
399
Services billed
5,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide78$82,481
OzempicSemaglutide86$81,633
EliquisApixaban60$47,724
JardianceEmpagliflozin38$38,491
LinzessLinaclotide30$23,480
TrulicityDulaglutide19$17,549
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,771
FarxigaDapagliflozin Propanediol13$10,927
JanuviaSitagliptin Phosphate13$9,256
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,674
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,059
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$6,756
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$6,638
SynthroidLevothyroxine Sodium63$4,276
Albuterol Sulfate HfaAlbuterol Sulfate137$3,197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$32$100,02997 claims
Novo NordiskOzempic$39$81,63386 claims
Boehringer IngelheimJardiance$28$38,49138 claims
AbbVieLinzess, Synthroid$91$27,75693 claims
AstraZenecaFarxiga, Breztri Aerosphere$52$19,60227 claims
MerckJanuvia$20$9,25613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Cabot

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →